Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.025
-0.105 (-3.35%)
Nov 21, 2024, 11:44 AM EST - Market open

Zentalis Pharmaceuticals Revenue

Zentalis Pharmaceuticals had revenue of $40.56M in the twelve months ending September 30, 2024.

Revenue (ttm)
$40.56M
Revenue Growth
n/a
P/S Ratio
5.48
Revenue / Employee
$327,097
Employees
124
Market Cap
215.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.79B
High Tide 370.02M
MacroGenics 141.33M
Genfit 86.23M
SOPHiA GENETICS 64.49M
Editas Medicine 61.76M
Molecular Partners AG 7.11M
Orchestra BioMed Holdings 2.65M
Revenue Rankings